MENU

MXCT Stock Tickeron detected bullish Stock Pattern: Broadening Wedge Descending MXCT on November 17, 2025, netting in a 10.88% gain over 1 week

A.I.dvisor
at Tickeron.com
Loading...
+10.88% Gain from a Successful pattern Broadening Wedge Descending
MXCT - MaxCyte
Tickeron
Ticker: MXCT
Company: MaxCyte
Gain: +10.88%
Confirmed: 11/17/25
Succeeded: 11/17/25
Total length: 11 days

On November 06, 2025, A.I.dvisor detected a Broadening Wedge Descending Pattern (Bullish) for MaxCyte (MXCT, $1.47). On November 17, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $1.75. On November 17, 2025, MXCT reached the target price resulting in a +1 for traders who took a long position in the stock.

MXCT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MXCT turned positive on November 17, 2025. Looking at past instances where MXCT's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on MXCT as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MXCT moved above its 50-day moving average on November 14, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MXCT advanced for three days, in of 208 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for MXCT crossed bearishly below the 50-day moving average on November 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MXCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MXCT broke above its upper Bollinger Band on October 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MXCT entered a downward trend on November 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.965) is normal, around the industry mean (62.926). P/E Ratio (0.000) is within average values for comparable stocks, (35.899). MXCT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.667). MXCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (5.025) is also within normal values, averaging (84.432).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MXCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MXCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MXCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MXCT showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
9713 Key West Avenue
Phone
+1 301 944-1700
Employees
143
Web
https://www.maxcyte.com